Pfizer said on Friday it has received an early clearance from the U.S. Federal Trade Commission for its proposed acquisition ...
Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based ...
Pfizer said on Friday it had filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement ...
U.S. drugmaker Pfizer could work its connections within President Donald Trump's administration to try to thwart Novo Nordisk ...
The Wegovy and Ozempic maker’s offer comes after Pfizer last month agreed to a lower deal to acquire the Nasdaq-listed ...
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
TLDR Novo Nordisk launched an unsolicited $9 billion offer for Metsera, trumping Pfizer’s existing $7.3 billion acquisition ...
Novo Nordisk has submitted an unsolicited bid to buy obesity biotech Metsera out from under Pfizer, offering $6 billion ...
Last month, it announced plans to acquire Metsera, a clinical-stage biopharmaceutical company accelerating the next ...
Denmark's Novo Nordisk launched a rival bid for U. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...
A bidding war has broken into the open for the obesity-focused Metsera, with Novo Nordisk aiming to outbid Pfizer for the ...
I don’t know what to say about Pfizer. I mean, it’s got that yield of 7%. It bought that Seagen. I thought it was going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback